New study identifies signature in blood to better predict type 2 diabetes risk
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Jun-2026 02:16 ET (9-Jun-2026 06:16 GMT/UTC)
A new study offers a solution to infections with the pathogenic fungus Candida auris by taking a new precision diagnostic approach that for the first time enables fast and accurate quantification of C. auris strains from easily obtained swab samples, as well as the quantification of AMR-causing mutations in fungal populations with mixed antifungal susceptibility. The next-generation test builds on previous diagnostic accomplishments of the groups of Wyss Institute Core Faculty members David Walt, Ph.D. and James Collins, Ph.D., who led the effort, and was greatly facilitated by the team’s collaboration with the Wadsworth Center Mycology Lab at New York State Department of Health, which provided a first cohort of patient samples (surveillance swabs) for the team’s initial technology validation.
Researchers from DTU have patented an invention that uses naturally produced substances from gut bacteria of the bifidobacteria type to reduce the risk of allergies and asthma.
A new study shows that year-long home visits with older adults help first-year medical students build stronger communication skills, rethink assumptions about aging, and understand patient care beyond the clinic.
The University of Bath’s Tobacco Control Research Group publishes research into the impacts of flue-cured Virginia tobacco (FCV) in Zimbabwe
The production method makes tobacco products more addictive and causes deforestation of 60,000 hectares of woodland in Zimbabwe each year
Authors call for restrictions to the use of FCV in tobacco products, and for farmers to be supported in diversifying into growing alternative crops
Researchers analysed tobacco industry documents and conducted fieldwork with tobacco industry and forestry key informants as well as smallholding farmers in Zimbabwe to understand its economic and environmental effects
Tendons are strong – but not invincible. If repeatedly overloaded, for example during intense training, they can undergo gradual but harmful changes with debilitating pain.
A protein known as HIF1 is central to these changes, as researchers have now demonstrated in experiments in mice and with tendon tissue from humans.
Their findings open a path to new treatments that could act before the tissue is irreversibly damaged.